Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Neurotherapeutics (Editorial Board)



The Journal of the American Society for Experimental NeuroTherapeutics

Editor-in-Chief: Maral Mouradian

ISSN: 1933-7213 (print version)
ISSN: 1878-7479 (electronic version)

Journal no. 13311

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy


M. Maral Mouradian, MD, Rutgers-Robert Wood Johnson Medical School

Associate Editors:

Gregory Bergey, MD, Johns Hopkins University School of Medicine

Raymond Swanson, MD, University of California, San Francisco

Editorial Board:

Robert H. Baloh, MD, PhD, Cedars-Sinai Medical Center

M. Flint Beal, MD, Weill Medical College of Cornell University

David Brooks, MD, GE Healthcare

Amy Brooks-Kayal, MD, University of Colorado School of Medicine

Ashley Bush, MD, University of Melbourne

Rudolph J. Castellani, MD, University of Maryland School of Medicine

Jun Chen, MD, PhD, University of Pittsburgh School of Medicine

Marie-Francoise Chesselet, MD, PhD, University of California, Los Angeles

Jeffrey A. Cohen, MD, Cleveland Clinic

Merit Cudkowicz, MD, Massachusetts General Hospital

Steven T. DeKosky, MD, University of Florida

Mahlon DeLong, MD, Emory University

W. Dalton Dietrich, PhD, University of Miami Miller School of Medicine

Bruce H. Dobkin, MD, University of California, Los Angeles

Susan G. Dorsey, PhD RN, FAAN, University of Maryland Baltimore

Stewart A. Factor, DO, Emory University

Alan I. Faden MD, University of Maryland School of Medicine

Howard J. Federoff, MD, PhD, University of California, Irvine

David J. Fink, MD, University of Michigan

Gary Fiskum, PhD, University of Maryland

Joel D. Greenspan, PhD, University of Maryland School of Dentistry

Robert C. Griggs, MD, University of Rochester

Edward D. Hall, PhD, University of Kentucky

Mark Hallett, MD, National Institute of Neurological Disorders and Stroke

Karl Herholz, MD, University of Manchester

Joseph Jankovic, MD, Baylor College of Medicine

Jeffrey H. Kordower, PhD, Rush University Medical Center

Gary Landreth, MD, Case Western Reserve University

Catherine Lomen-Hoerth, MD, PhD, University of California, San Francisco

Frank M. Longo, MD, PhD, Stanford University

Pedro Lowenstein, MD, PhD, University of Michigan Medical School  

Andres Lozano, MD, PhD, Toronto Western Research Institute

John W. Miller, MD, PhD, University of Washington

Hideki Mochizuki, MD, PhD, Osaka University

Andrew A. Pieper, MD, PhD, University of Iowa Carver College of Medicine

Rajiv R. Ratan, MD, PhD, Burke-Cornell Medical Research Institute

Michael A. Rogawski, MD, PhD, University of California, Davis

Jeffrey D. Rothstein, MD, PhD, Johns Hopkins School of Medicine

Richard A. Rudick, MD, Biogen Idec

Christine Sang, MD, MPH, Brigham and Women’s Hospital

Steven Schachter, MD, Beth Israel Deaconess Medical Center

Magdy Selim, MD, PhD, Harvard Medical School

Jeremy M. Shefner, MD, PhD, Barrow Neurological Institute, AZ

Solomon H. Snyder, MD, Johns Hopkins School of Medicine

Thomas Sutula, MD, PhD, University of Wisconsin

Michael Wang, MD, PhD, University of Michigan

Patrick Y. Wen, MD, Brigham and Women’s Hospital

Heinz Wiendl, MD, PHD, University of Muenster

V. Wee Yong, PhD, University of Calgary

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 5.719
  • Aims and Scope

    Aims and Scope


    Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. 

    The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

    Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

    Future Theme Issues:

    October 2018- Advances and Challenges in the Diagnosis and Management of Myopathies Guest Editor: Andrew Mammen (NIH), Doris Leung (JHMI), Ricardo Roda (JHMI)

    January 2019- Innovation and Evolution in Surgical Neurotherapeutics                              Guest Editor: Mark Richardson (UPMC), Taylor Abel (UPMC)

    April 2019- Nucleic Acid-based Therapeutics in Neurology                                                   Guest Editor: Robert Brown (U-MASS), Anastasia Khvorova (U-MASS), Jonathan Watts (U-MASS)

    July 2019- Protection of the Aging Brain                                                                                 Guest Editor: Andrew Pieper (U Iowa), Alan Lerner (CWRU)

    October 2019- Molecular Pathogenesis and Advances in Therapeutics of Trinucleotide Repeat Expansion Disorders                                                                                                      Guest Editor: Lisa Ellerby (Buck Inst)

    January 2020- Neurobiological Targets in Translational Addiction Research                          Guest Editor: Jesse Schank (U-GA), Carolina Haass-Koffler (Brown)

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors (pdf, 200 kB)
  • Conflict of Interest Form (pdf, 494 kB)

Alerts for this journal


Get the table of contents of every new issue published in Neurotherapeutics.